Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(17/week)
News
United States
(590/week)
Manufacturing
(411/week)
Energy
(331/week)
Technology
(419/week)
Other Energy
(294/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Curis, Inc.
Feb 19, 2021
Curis to Present at SVB Leerink 10th Annual Global Healthcare Conference
Feb 02, 2021
Curis Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes
Jan 08, 2021
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 05, 2021
Curis to Present at H.C. Wainwright & Co. Bioconnect 2021 Virtual Conference
Dec 14, 2020
Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Dec 09, 2020
Curis Announces Pricing of Public Offering of Common Stock
Dec 08, 2020
Curis Announces Proposed Public Offering of Common Stock
Dec 08, 2020
Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
Dec 07, 2020
Curis Announces Updated Preliminary Data from Ongoing Phase 1 Study of CA-4948 Showing Durable and Dose-Dependent Reductions in Tumor Burden in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
Dec 02, 2020
Curis to Host Virtual Event to Discuss CA-4948 Clinical Data
Nov 10, 2020
Curis Announces Collaboration with the National Cancer Institute for the Development of IRAK4 Inhibitor, CA-4948, as an Anti-Cancer Agent
Nov 04, 2020
Curis Announces Three Abstracts for CA-4948 Accepted for Presentation at the 62nd American Society of Hematology Annual Meeting and Exposition
Nov 02, 2020
Curis to Release Third Quarter 2020 Financial Results and Hold Conference Call on November 10, 2020
Oct 21, 2020
Curis Highlights Publication in ACS Medicinal Chemistry Letters Showcasing Targeted Potency and Ideal Pharmacologic Properties of CA-4948 for Treatment of Hematologic Malignancies
Oct 14, 2020
Curis Announces Abstract for CI-8993 Accepted for Presentation at the Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting
Jul 07, 2020
Curis Doses First Patient in Phase 1 Study of CA-4948 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
Jun 11, 2020
Curis Announces $17.5 Million Registered Direct Offering
Jun 10, 2020
Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody
May 12, 2020
Curis Reports First Quarter 2020 Financial Results
Apr 07, 2020
Curis to Present at 19th Annual Needham Virtual Healthcare Conference
Page 1
››
Latest News
May 14, 2024
OMNIVISION Expands Automotive TheiaCel™ Technology Portfolio with New 5MP Image Sensor
May 14, 2024
FLOR Launches New Area Rug Styles to Usher in the Summer Season
May 14, 2024
C3 AI and Bloom Energy Team Up to Revolutionize Fuel Cell Performance, Service, and Engineering Analytics
May 14, 2024
SheerID Launches Suite of Marketing Products Equipping Brands to Reach Entire Communities of Students,...
May 14, 2024
8x8 Partners with Military Makeover to Honor and Support Veterans
May 14, 2024
Aurora Solar Appoints Patrick Donahue as Chief Product Officer and Promotes Carina Brockl to Chief Revenue...
May 14, 2024
Multiply Labs and Retro Biosciences Announce an $85 Million Partnership to Advance Cell Therapy Manufacturing...
May 14, 2024
Rootstock Recognized as Best Cloud ERP with Gold Stevie® Award
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events